Morgan Stanley’s $2.4 billion Facebook short | Felix Salmon
Morgan Stanley’s $2.4 billion Facebook short By Felix Salmon MAY 21, 2012 Matt Levine had a very wonky post on Friday afternoon about the dynamics of the Facebook IPO in general and of the very…
Bond exodus on a par with eurozone bank run - FT.com
Bond exodus on a par with eurozone bank run By Richard Milne A great deal of attention is being heaped on the possibility of a bank run across the eurozone. But something just as important is…
CME Group scores 3 on our checklist, but provides strong dividend yield and growth potential
CHART- know how to read charts. I firmly believe I can improve the price of buying or selling from an understanding of chart action. Recent bullish divergence has been observed; +1 …
European Banks Unprepared for Greek Exit From Euro - Yahoo! Finance
European Banks Unprepared for Greek Exit From EuroBy Elena Logutenkova, Liam Vaughan and Gavin Finch | Bloomberg – 1 hour 27 minutes ago Europe's banks, sitting on $1.19 trillion of debt to Spain,…
NYX, NYSE Euronext scores a 3 on our checklist
CHART- know how to read charts. I firmly believe I can improve the price of buying or selling from an understanding of chart action. First bullish divergence seen since October of 2011; +1 …
JPMorgan Risk Chief Had History of Trading Losses and Sanctions - Wall Street & Technology
PMorgan Risk Chief Had History of Trading Losses and Sanctions Goldman's previous Wall Street firm received a slap on the wrist from regulators. By Melanie Rodier@mrodier MAY 21, 2012 Share on email…
Facebook debacle NYSE gain, Nasdaq's pain
Although NYSE lost the Facebook listing, the way Nasdaq bumbled it is surely to help the NYSE long term. According to Barron's article April 21st, "Even as it invests in its technology and…
How bad was last week?
Dow took its losing streak to six days, and has now fallen in 12 of the past 13 days. The WSJ points out that the last time the Dow suffered as many losses over a 13-day stretch was in October 1974,…
PharMerica revisited
April 13th we wrote that PharMerica was right to turn down Omincare's $15 per share offer. Since that time PMC has continued to underperform the market declining twice as much as the market as a…
Do you believe a good company will come back from a 20% price decline?
I certainly do. I'm talking about Hess Oil. HES. Let's revisit the stock checklist. Hess Oil scores a 8, the highest rating I've yet to see any stock achieve. Not only do I believe it will come…